Starting titrating and intensifying metformin
Abstract
Most persons with type 2 diabetes are treated with oral anti diabetic drugs (OADs). The drug of choice for initiating OAD therapy, in most cases, is metformin. This communication discusses how to start, titrate, and intensify metformin therapy in primary care. It discusses ways of improving tolerance to, and enhancing acceptability of, metformin in people with diabetes.
Read the paper
Related studies
- Metformin as an adjuvant in breast cancer treatment
- Metformin Lysosomal Targeting: A Novel Aspect to Be Investigated for Metformin Repurposing in Neurodegenerative Diseases?
- Aberrant HSF1 signaling activation underlies metformin amelioration of myocardial infarction in mice
- Metformin induces ZFP36 by mTORC1 inhibition in cervical cancer-derived cell lines
- Protein Interaction Network for Identifying Vascular Response of Metformin (Oral Antidiabetic)
- Preventing Long COVID With Metformin
Go deeper in Evidence Hub
Evidence Hub adds a study data sheet (design, sample size, evidence level, key numbers), an AI summary and a chat grounded in the paper's text.